{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:33:24Z","timestamp":1791318804135,"version":"4.3.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.exer.2005.09.003","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T14:54:33Z","timestamp":1138373673000},"page":"657-663","source":"Crossref","is-referenced-by-count":76,"title":["Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate"],"prefix":"10.1016","volume":"82","author":[{"given":"Tsutomu","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumu","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saburo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2005.09.003_bib1","first-page":"2195","article-title":"Resident and infiltrating immune cells in the early and late stages of experimental autoimmune uveoretinis","volume":"37","author":"Bulter","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.09.003_bib2","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1002\/eji.200425022","article-title":"Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis","volume":"34","author":"de Kozak","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.exer.2005.09.003_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/bjo.77.3.171","article-title":"Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis, A preliminary report of intranasal induction of tolerance with retinal antigens","volume":"77","author":"Dick","year":"1993","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.003_bib4","series-title":"Meyler's Side Effects of Drugs","first-page":"1189","article-title":"Corticotrophins and corticosteroids","author":"Dukes","year":"1996"},{"key":"10.1016\/j.exer.2005.09.003_bib5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/02713689808951224","article-title":"Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats","volume":"17","author":"Forrester","year":"1998","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2005.09.003_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0142-9612(95)93258-F","article-title":"Hydrolytic degradation of devices based on poly (dl-lactic acid) size-dependence","volume":"16","author":"Grizzi","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.exer.2005.09.003_bib7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/ard.2004.030759","article-title":"Treatment of experimental arthritis with PLGA nanoparticles encapsulating betamethasone sodium phosphate","volume":"64","author":"Higaki","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.exer.2005.09.003_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0021-5155(02)00538-5","article-title":"Suppression of experimental autoimmune uveoretinitis by anti-\u03b1\u03b2 TCR monoclonal antibody","volume":"46","author":"Inoki","year":"2002","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.003_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2005.02.026","article-title":"Role of zinc in formulation of PLGA\/PLA nanoparticles encapsulating betamethasone phosphate and its release profile","volume":"105","author":"Ishihara","year":"2005","journal-title":"J. Controlled Release."},{"key":"10.1016\/j.exer.2005.09.003_bib10","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(00)00466-8","article-title":"Fluocinolone acetonide sustained drug delivery device to treat severe uveitis","volume":"107","author":"Jaffe","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2005.09.003_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00417-003-0753-2","article-title":"Effects of a new dexamethasone-delivery system (Surodex) on experimental intraocular inflammation models. Greafe's","volume":"241","author":"Kodama","year":"2003","journal-title":"Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.003_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0168-3659(93)90097-O","article-title":"Preparation of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide\/glycolide copolymer (PLGA) by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior","volume":"25","author":"Niwa","year":"1993","journal-title":"J. Controlled. Release."},{"key":"10.1016\/j.exer.2005.09.003_bib13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1167\/iovs.02-0375","article-title":"Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate","volume":"44","author":"Okabe","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.09.003_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0169-409X(97)00050-1","article-title":"One-and three-month release injectable microsheres of the LH-RH superagonist leuprorelin acetate","volume":"28","author":"Okada","year":"1997","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.exer.2005.09.003_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0168-3659(94)90159-7","article-title":"Drug delivery using biodegradable microspheres","volume":"28","author":"Okada","year":"1994","journal-title":"J. Control. Release."},{"key":"10.1016\/j.exer.2005.09.003_bib16","series-title":"The Macula","first-page":"261","article-title":"Recent trends in ocular drug delivery","author":"Parel","year":"2004"},{"key":"10.1016\/j.exer.2005.09.003_bib17","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.4049\/jimmunol.140.7.2193","article-title":"Glial retinal M\u00fcller cells produce IL-1 activity and have a dual effect on autoimmune T helper lymphocytes. Antigen presentation manifested after removal of suppressive activity","volume":"140","author":"Roberge","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2005.09.003_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000310145","article-title":"Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease","volume":"201","author":"Sasamoto","year":"1990","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.exer.2005.09.003_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i1.20","article-title":"Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems","volume":"19","author":"Schwendeman","year":"2002","journal-title":"Crit. Rev. Ther. Drug. Carrier Syst."},{"key":"10.1016\/j.exer.2005.09.003_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2249.1997.4571356.x","article-title":"Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals","volume":"109","author":"Thurau","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.exer.2005.09.003_bib21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/bjo.86.5.521","article-title":"High dose intravenous steroid therapy for severe posterior segment uveitis in Behcet's disease","volume":"86","author":"Toker","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.003_bib22","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/sj.gt.3302101","article-title":"Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis","volume":"10","author":"Verwaerde","year":"2003","journal-title":"Gene. Ther."},{"key":"10.1016\/j.exer.2005.09.003_bib23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archopht.1986.01050180081035","article-title":"Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease","volume":"104","author":"Wakefield","year":"1986","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.003_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1442-9071.2000.00282.x","article-title":"Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis","volume":"28","author":"Wakefield","year":"2000","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.003_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/71916","article-title":"Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)","volume":"18","author":"Zhu","year":"2000","journal-title":"Nat. Biotechnol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483505002927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483505002927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T09:50:23Z","timestamp":1683366623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483505002927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0014483505002927"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2005.09.003","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}